Back to Search
Start Over
A transgenic mouse model for Alzheimer's disease has impaired synaptic gain but normal synaptic dynamics
- Source :
- Neuroscience Letters. 500:212-215
- Publication Year :
- 2011
- Publisher :
- Elsevier BV, 2011.
-
Abstract
- The chronic accumulation of amyloid beta (Aβ) peptides is thought to underlie much of the pathology of Alzheimer's disease (AD), and transgenic mice overexpressing Aβ show both behavioral defects and impairments in hippocampal synaptic transmission. In the present study, we examined excitatory transmission at the Schaffer collateral synapse in acute hippocampal slices from APPSwe/PS-1A246E transgenic mice to determine whether the synaptic impairment in these mice is due to a reduction in the activity-independent synaptic gain, or to a change in the activity-dependent synaptic dynamics. We observed a strong reduction in synaptic transmission in slices from APPSwe/PS-1A246E mice compared to those from their wildtype littermates. However, there was no resolvable change in the synaptic dynamics observed in response to either simple or complex stimulus trains. We conclude that the chronic accumulation of Aβ impairs synaptic transmission through a reduction in the synaptic gain, while preserving the synaptic dynamics.
- Subjects :
- Amyloid beta
Mice, Transgenic
In Vitro Techniques
Neurotransmission
Hippocampus
Synaptic Transmission
Article
Amyloid beta-Protein Precursor
Mice
Alzheimer Disease
Presenilin-1
medicine
Animals
biology
General Neuroscience
Glutamate receptor
Excitatory Postsynaptic Potentials
Long-term potentiation
medicine.anatomical_structure
Synaptic fatigue
Schaffer collateral
Synapses
Synaptic plasticity
biology.protein
Excitatory postsynaptic potential
Neuroscience
Subjects
Details
- ISSN :
- 03043940
- Volume :
- 500
- Database :
- OpenAIRE
- Journal :
- Neuroscience Letters
- Accession number :
- edsair.doi.dedup.....b929d0e9fac8d43e205dee386507df65
- Full Text :
- https://doi.org/10.1016/j.neulet.2011.06.043